Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course

Introduction Immunomodulators such as thiopurines (azathioprine (AZA)/6-mercaptopurine (6MP)), methotrexate (MTX) and biologics such as adalimumab (ADA) are well established for maintenance of remission within paediatric Crohn’s disease (CD). It remains unclear, however, which maintenance medication...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Sibylle Koletzko, Richard K Russell, Arie Levine, Dan Turner, Rachel E Harris, Lissy de Ridder, Frank M Ruemmele, Nicholas M Croft, Marina Aloi, Gigi Veereman, Mattias Neyt, Laetitia Bigot
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMJ Publishing Group 2020-07-01
Ráidu:	BMJ Open
Liŋkkat:	https://bmjopen.bmj.com/content/10/7/e034892.full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!